rs1525047
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001321708.2(DGKI):c.1948-1499C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 152,112 control chromosomes in the GnomAD database, including 2,055 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 2055 hom., cov: 32)
Consequence
DGKI
NM_001321708.2 intron
NM_001321708.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.194
Publications
0 publications found
Genes affected
DGKI (HGNC:2855): (diacylglycerol kinase iota) This gene is a member of the type IV diacylglycerol kinase subfamily. Diacylglycerol kinases regulate the intracellular concentration of diacylglycerol through its phosphorylation, producing phosphatidic acid. The specific role of the enzyme encoded by this gene is undetermined, however, it may play a crucial role in the production of phosphatidic acid in the retina or in recessive forms of retinal degeneration. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DGKI | NM_001321708.2 | c.1948-1499C>T | intron_variant | Intron 19 of 32 | ENST00000614521.2 | NP_001308637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DGKI | ENST00000614521.2 | c.1948-1499C>T | intron_variant | Intron 19 of 32 | 5 | NM_001321708.2 | ENSP00000479053.2 |
Frequencies
GnomAD3 genomes AF: 0.109 AC: 16611AN: 151992Hom.: 2054 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16611
AN:
151992
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.109 AC: 16635AN: 152112Hom.: 2055 Cov.: 32 AF XY: 0.110 AC XY: 8178AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
16635
AN:
152112
Hom.:
Cov.:
32
AF XY:
AC XY:
8178
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
12351
AN:
41424
American (AMR)
AF:
AC:
1962
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
32
AN:
3470
East Asian (EAS)
AF:
AC:
687
AN:
5174
South Asian (SAS)
AF:
AC:
530
AN:
4816
European-Finnish (FIN)
AF:
AC:
56
AN:
10604
Middle Eastern (MID)
AF:
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
AC:
784
AN:
68016
Other (OTH)
AF:
AC:
195
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
618
1237
1855
2474
3092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
343
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.